Cameron Turtle Insider Profile

4 Followers
Cameron Turtle, CBO at Eidos Therapeutics, holds 746.91K shares in Spyre Therapeutics (Ticker: SYRE), holds 12.57K shares in BridgeBio Pharma (Ticker: BBIO), holds 50.62K shares in Eidos Therapeutics (Ticker: EIDX).
tipranks
Cameron Turtle

Cameron Turtle
Eidos Therapeutics (EIDX)
CBO

Ranked #92,390 out of 99,218 Corporate Insiders

Profitable Transactions

25%
1 out of 4 Profitable Transactions

Average Return

-57.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$30M
98.86%
1.14%
A breakdown of Cameron Turtle's holdings

Insider Roles

Spyre Therapeutics
(SYRE)
CEO, Director
BridgeBio Pharma
(BBIO)
SVP, Portfolio Management and Corporate Developmen
Roles that Cameron Turtle holds in companies

Most Profitable Insider Trade

Stock:
Eidos Therapeutics
(EIDX)
Rating:Informative Sell
Date:Sep 06, 2019 - Sep 06, 2020
Return:+2.10%
The most profitable trade made by Cameron Turtle

Cameron Turtle's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
EIDX
Eidos Therapeutics
Nov 13, 2020
Uninformative Sell
$6.19M
BridgeBio Pharma
Dec 29, 2020
SVP, Portfolio Management and Corporate Developmen
Uninformative Buy
130.50K
$340.47K
Spyre Therapeutics
Feb 20, 2024
CEO, Director
Uninformative Buy
3.93K
$29.56M
List of latest transactions for each holding click on a transaction to see Cameron Turtle's performance on stock

Cameron Turtle insider profile FAQ

What is the percentage of profitable transactions made by Cameron Turtle?
The percentage of profitable transactions made by Cameron Turtle is 25%.
    What is the average return per transaction made by Cameron Turtle?
    The average return per transaction made by Cameron Turtle is -57.20%.
      What stocks does Cameron Turtle hold?
      Cameron Turtle holds: EIDX, BBIO, SYRE stocks.
        What was Cameron Turtle’s latest transaction?
        Cameron Turtle latest transaction was an Uninformative Buy of $3.93K.
          What was Cameron Turtle's most profitable transaction?
          Cameron Turtle’s most profitable transaction was an Informative Sell of EIDX stock on September 6, 2019. The return on the trade was 2.10%.
            What is Cameron Turtle's role in Eidos Therapeutics?
            Cameron Turtle's role in Eidos Therapeutics is CBO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.